On July 26th, Healx, a four-year-old Cambridge (UK) technology company that develops innovative drugs for rare diseases, announced a $10 million Series A funding round, led by Balderton Capital. Previous Healx investors, Jonathan Milner and Amadeus Capital Partners, also took part in the round. Healx focuses on rare diseases, 95 percent of which have no … Continue reading Artificial Intelligence Startup Healx Gets $10 Million to Find Cures for Rare Diseases